feed,title,long_url,short_url
Benzinga,Return On Capital Employed Overview: Information Services,https://benzinga.com/news/21/06/21704716/return-on-capital-employed-overview-information-services,https://j.mp/3d90Jvl
Benzinga,Looking Into Revance Therapeutics's Return On Capital Employed,https://benzinga.com/news/21/06/21704714/looking-into-revance-therapeuticss-return-on-capital-employed,https://j.mp/3jhgnbA
Benzinga,Return On Capital Employed Overview: Castle Biosciences,https://benzinga.com/news/21/06/21704710/return-on-capital-employed-overview-castle-biosciences,https://j.mp/3qmYs4U
Benzinga,Cherry Hill Mortgage: Return On Capital Employed Insights,https://benzinga.com/news/21/06/21704701/cherry-hill-mortgage-return-on-capital-employed-insights,https://j.mp/3gUhCvK
Benzinga,Return On Capital Employed Overview: Arcturus Therapeutics,https://benzinga.com/news/21/06/21704696/return-on-capital-employed-overview-arcturus-therapeutics,https://j.mp/2Uoq11N
Benzinga,Vuzix: Return On Capital Employed Insights,https://benzinga.com/news/21/06/21704693/vuzix-return-on-capital-employed-insights,https://j.mp/3xP2J3H
Benzinga,Return On Capital Employed Overview: Geron,https://benzinga.com/news/21/06/21704689/return-on-capital-employed-overview-geron,https://j.mp/3zTdgg6
Benzinga,Return On Capital Employed Overview: Omeros,https://benzinga.com/news/21/06/21704682/return-on-capital-employed-overview-omeros,https://j.mp/3wPlMuy
Benzinga,Inovio Pharmaceuticals: Return On Capital Employed Insights,https://benzinga.com/news/21/06/21704674/inovio-pharmaceuticals-return-on-capital-employed-insights,https://j.mp/3gUlRpW
Benzinga,Return On Capital Employed Overview: Mesa Air Group,https://benzinga.com/news/21/06/21704664/return-on-capital-employed-overview-mesa-air-group,https://j.mp/3vTLHQC
Benzinga,Return On Capital Employed Overview: Mersana Therapeutics,https://benzinga.com/news/21/06/21704656/return-on-capital-employed-overview-mersana-therapeutics,https://j.mp/3gS4x6v
Benzinga,Looking Into PAR Technology's Return On Capital Employed,https://benzinga.com/news/21/06/21704648/looking-into-par-technologys-return-on-capital-employed,https://j.mp/3qlxPxp
Benzinga,Looking Into Everbridge's Return On Capital Employed,https://benzinga.com/news/21/06/21704635/looking-into-everbridges-return-on-capital-employed,https://j.mp/3vTLPPV
Benzinga,Magnite Insights: Return On Capital Employed,https://benzinga.com/news/21/06/21704631/magnite-insights-return-on-capital-employed,https://j.mp/2U0XqzD
Benzinga,Return On Capital Employed Overview: Novavax,https://benzinga.com/news/21/06/21704623/return-on-capital-employed-overview-novavax,https://j.mp/3zWMvXW
